Melitracen Market

Melitracen (brand names Melixeran) is a tricyclic antidepressant (TCA), for the treatment of depression and anxiety. In addition to single drug preparations, it is also available as Deanxit, marketed by Lundbeck, a combination product containing both melitracen and flupentixo
Melitracen Market contains market size and forecasts of Melitracen in global, including the following market information:
Global Melitracen Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Melitracen Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Melitracen companies in 2021 (%)
The global Melitracen market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Drug Preparations Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Melitracen include Lundbeck, General Pharma, Rangs Group, Unimed and Unihealth, Drug International, Somatec Pharmaceuticals, Mankind Pharma, Molekule and Helios Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Melitracen manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Melitracen Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Melitracen Market Segment Percentages, by Type, 2021 (%)
Single Drug Preparations
Mixture Drug Preparations
Global Melitracen Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Melitracen Market Segment Percentages, by Application, 2021 (%)
Hospital
Drug Store
Global Melitracen Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Melitracen Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Melitracen revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Melitracen revenues share in global market, 2021 (%)
Key companies Melitracen sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Melitracen sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lundbeck
General Pharma
Rangs Group
Unimed and Unihealth
Drug International
Somatec Pharmaceuticals
Mankind Pharma
Molekule
Helios Pharmaceutical
East West Pharma
Union Medical
Aristopharma
Bio-Pharma
ACI Pharmaceuticals